LV12803B - Tablet matrix for prolonged release of gliclazide - Google Patents

Tablet matrix for prolonged release of gliclazide

Info

Publication number
LV12803B
LV12803B LVP-00-114A LV000114A LV12803B LV 12803 B LV12803 B LV 12803B LV 000114 A LV000114 A LV 000114A LV 12803 B LV12803 B LV 12803B
Authority
LV
Latvia
Prior art keywords
gliclazide
prolonged release
tablet matrix
liberation
regular
Prior art date
Application number
LVP-00-114A
Other languages
Latvian (lv)
Other versions
LV12803A (en
Inventor
Bruno Huet De Barochez
Patrick Wuthrich
Louis Martin
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Priority to LVP-00-114A priority Critical patent/LV12803B/en
Publication of LV12803A publication Critical patent/LV12803A/en
Publication of LV12803B publication Critical patent/LV12803B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invention relates to producing tablets for oral administration facilitating prolonged release of gliclazide ensuring permanent and regular liberation of biologically active substance independently of changes of pH in gastroenteric system.
LVP-00-114A 2000-08-30 2000-08-30 Tablet matrix for prolonged release of gliclazide LV12803B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-00-114A LV12803B (en) 2000-08-30 2000-08-30 Tablet matrix for prolonged release of gliclazide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-00-114A LV12803B (en) 2000-08-30 2000-08-30 Tablet matrix for prolonged release of gliclazide

Publications (2)

Publication Number Publication Date
LV12803A LV12803A (en) 2002-03-20
LV12803B true LV12803B (en) 2002-07-20

Family

ID=19735213

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-114A LV12803B (en) 2000-08-30 2000-08-30 Tablet matrix for prolonged release of gliclazide

Country Status (1)

Country Link
LV (1) LV12803B (en)

Also Published As

Publication number Publication date
LV12803A (en) 2002-03-20

Similar Documents

Publication Publication Date Title
MXPA02012793A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition.
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
IL145783A0 (en) Fast-dispersing dosage forms containing fish gelatin
ATE211907T1 (en) OSMOTIC DRUG RELEASE SYSTEM
RS52577B (en) Once-a-day oxycodone formulations
NO993520D0 (en) Dosage forms and methods for improving erectile dysfunction
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
PL367277A1 (en) Methods of making sustained release formulations of oxymorphone related applications
TW200633730A (en) Oral disintegrating dosage forms
IL143375A0 (en) Sustained release matrix systems for highly soluble drugs
PL344564A1 (en) Matrix tablet enabling prolonged release of trimethiazidine after oral administration and method of making such tablet
ATE243504T1 (en) CEFADROXIL MONOHYDRATE TABLET FORMULATION
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
BR0013719A (en) Controlled-release oral dosage, suitable for oral administration
MX9706053A (en) Trimebutine maleate tablet with laminar covering.
MY137516A (en) Pharmaceutical composition comprising lumiracoxib
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
LV12803B (en) Tablet matrix for prolonged release of gliclazide
IL157539A0 (en) A stable pharmaceutical formulation comprising torsemide modification ii
MXPA01008348A (en) Microcapsules for sustained release of drugs.
ATE302010T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DEOXYPEGANINE FOR THE TREATMENT OF ALCOHOLISM
LT2000081A (en) Core tablet for controlled release of gliclazide after oral administration
JO2173B1 (en) Materix tablet enabling prolonged release of gliclazide after administration by the oral route.
GEP20063804B (en) Once-a-day oxycodone formulations